Jean-Coutu Pavillon, Room 2242
Phone: 514-343-6111 #3149
Fax: 514-343-6120
E-mail: sylvie.perreault@umontreal.ca

 

Chaire pharmaceutique sanofi aventis sur l'utilisation des médicaments: politiques et résultantes

 

Teaching Domains

• Pharmacoeconomy

• Methodology of research in pharmaceutical practice

• Strategy for the assessment of clinical efficacy of medication

• Planification and organisation of research protocol

Research Themes

• Pharmacoéconomy

• Pharmacoepidemiology

• Evaluation of drug utilization and its determinants

• Evaluation of drug effectiveness and its impact on health care use and its related costs in clinical setting

Current Research Projects

• Pharmacoeconomic and pharmacoepidemiologic studies of cardiovascular disease, osteoporosis and mental health

• Assessment of drug utilization and its determinants of cardiovascular disease, osteoporosis and mental health

• Assessment of clinical effectiveness of antihypertensive agents, lipid lowering drug, antiresorptive agents and their impact of health care use and its related costs

• Building economic model for the prevention and treatment of cardiovascular disease, osteoporosis and mental health

Selected publications

Kettani F*, Dragomir A, Côté R, Roy L, Bérard A, Blais L, Lalonde L, Moreau P, Perreault S.  Impact of a better adherence to antihypertensive agents adherence on cerebrovascular disease for primary prevention. Stroke 2009;40(1):213-220.

Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A.  Better adherence to antihypertensive agents and risk reduction of chronic heart failure (Accepted to J Int Med, February 2009).

Ellia L*, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L, Perreault S.  Effect of statin adherence on cerebrovascular disease in primay prevention (Accepted to Am J Med, January 2009).

Perreault S, Dragomir A, Blais L, Lalonde L, Bérard A, Pilon D. Impact of Adherence to Statins on Chronic Heart Failure in Primary Prevention. Br J Clin Pharmacol 2008;66(5):706-716S.

Blouin J*, Dragomir A, Ste-Marie LG, Fernandès JC, Perreault S. Comparison of osteoporosis-related direct health care cost among community-dwelling elderly women compliant and non compliant with alendronate and risedronate: a population-based study (Osteoporosis Int, December 2008, Epub ahead of print).

Blouin J*, Dragomir A, Moride Y, Ste-Marie LG, Fernandes JC, Perreault S.  Impact of nonadherence to bisphosphonates on the incidence of osteoporotic fractures: a nested case-control study. Br J Clin Pharmacol (E-pub, Mai 2008).

Blouin J*, Dragomir A, Ste-Marie LG, Fernandès JC, Perreault S. Persistence Rate and Adherence Level with Antiresorptive Therapies Used For Secondary Prevention of Osteoporosis among Elderly Women. J Clin Endo Metab 2007;92(3):887-894.

Perreault S, Levinton C, Moride Y, Laurier C, Ste-Marie LG, Crott R. Validation of decision model for preventive pharmacological strategies in postmenopausal women. Eur J Epidemiol 2005;20(1):89-101.

______________________

* student

 

Last update : 2010-06-01